Exact Mass: 285.0487754

C9H20NO3PS2 (285.06221800000003)

Prothoate

MFCD00049038

5-Deoxy-5-chloroadenosine

Fludarabine

Fludarabine Base

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor D000970 - Antineoplastic Agents Fludarabine (NSC 118218) is a DNA synthesis inhibitor and a fluorinated purine analogue with antineoplastic activity in lymphoproliferative malignancies. Fludarabine inhibits the cytokine-induced activation of STAT1 and STAT1-dependent gene transcription in normal resting or activated lymphocytes[1][2][3][4].

N-Acetylcytidine

N(4)-acetylcytidine

Cytidine in which one of the exocyclic amino hydrogens is substituted by an acetyl group. N4-Acetylcytidine is an endogenous metabolite. N4-Acetylcytidine is an endogenous metabolite.

4-nitrophenyl-alpha-l-fucopyranoside

p-Nitrophenyl 6-deoxy-alpha-L-galactopyranoside

N4-Acetylcytidine

N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}acetamide

N4-Acetylcytidine is a modified nucleoside. N4-acetylcytidine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285, 3506820) [HMDB] N4-Acetylcytidine is a modified nucleoside. N4-acetylcytidine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285, 3506820). N4-Acetylcytidine is an endogenous metabolite. N4-Acetylcytidine is an endogenous metabolite.

Cladribine

(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

Cladribine is only found in individuals that have used or taken this drug. It is an antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. [PubChem]Cladribine is structurally related to fludarabine and pentostatin but has a different mechanism of action. Although the exact mechanism of action has not been fully determined, evidence shows that cladribine is phosphorylated by deoxycytidine kinase to the nucleotidecladribine triphosphate (CdATP; 2-chloro-2â€²-deoxyadenosine 5â€²-triphosphate), which accumulates and is incorporated into DNA in cells such as lymphocytes that contain high levels of deoxycytidine kinase and low levels of deoxynucleotidase, resulting in DNA strand breakage and inhibition of DNA synthesis and repair. High levels of CdATP also appear to inhibit ribonucleotide reductase, which leads to an imbalance in triphosphorylated deoxynucleotide (dNTP) pools and subsequent DNA strand breaks, inhibition of DNA synthesis and repair, nicotinamide adenine dinucleotide (NAD) and ATP depletion, and cell death. Unlike other antimetabolite drugs, cladribine has cytotoxic effects on resting as well as proliferating lymphocytes. However, it does cause cells to accumulate at the G1/S phase junction, suggesting that cytotoxicity is associated with events critical to cell entry into S phase. It also binds purine nucleoside phosphorylase (PNP), however no relationship between this binding and a mechanism of action has been established. L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C471 - Enzyme Inhibitor > C2157 - Adenosine Deaminase Inhibitor C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D000970 - Antineoplastic Agents Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].

7-Aminoclonazepam

7-amino-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2-ol

7-aminoclonazepam belongs to the family of Benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms).

Faropenem

(+)-(5R,6S)-6-((1R)-1-Hydroxyethyl)-7-oxo-3-((2R)-tetrahydro-2-furyl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid

Faropenem is an orally active beta-lactam antibiotic belonging to the penem group. It is resistant to some forms of extended-spectrum beta-lactamase. It is available for oral use. Faropenem was developed by Daiichi Asubio Pharma, which markets it in two forms. The sodium salt faropenem sodium, available under the trade name Farom, has been marketed in Japan since 1997. (CID 636379 from PubChem) The prodrug form faropenem medoxomil (also known as faropenem daloxate) has been licensed from Daiichi Asubio Pharma by Replidyne, which plans to market it in conjunction with Forest Pharmaceuticals. The trade name proposed for the product was Orapem, but company officials recently announced this name was rejected by the FDA.

Asenapine

17-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(14),7,9,11,15,17-hexaene

2,5-Dioxopyrrolidin-1-yl quinolin-6-ylcarbamate

2,5-dioxopyrrolidin-1-yl N-(quinolin-6-yl)carbamate

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

2-Chloro-3'-deoxyadenosine

2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolan-3-ol

2-Fluoroadenosine

2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

5-(4-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

C14H8FN3O3 (285.054967)

arabinosyl-2-fluoroadenine

2-(6-amino-2-fluoro-7H-purin-8-yl)oxane-3,4,5-triol

9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine

9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine

C13H8ClN5O (285.0417348)

4-(2-Methoxyphenyl)-2-((5-methyl-1H-imidazol-4-yl)methyl)thiazole

4-(2-methoxyphenyl)-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1,3-thiazole

C10H11N3O5S (285.04193960000003)

Flunoxaprofen

2-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanoic acid

C16H12FNO3 (285.0801174)

Nifuratel

5-[(Methylsulphanyl)methyl]-3-{[(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one

2-Chloro-9-(2-deoxy-beta-D-arabinofuranosyl)adenine

5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

2-Amino-9-(6-oxo-1H-purin-9-yl)-1H-purin-6-one

C10H7N9O2 (285.0722682)

3H-1,4-Benzodiazepin-2-amine, 7-chloro-5-phenyl-, 4-oxide

7-chloro-2-imino-5-phenyl-3,4-dihydro-2H-1,4-benzodiazepin-4-ol

Theasaponin E3

(2S)-3-hydroxy-2-(2-nitrophenyl)-1,2,3,4-tetrahydroquinazolin-4-one

Theasaponin e3 is a member of the class of compounds known as quinazolines. Quinazolines are compounds containing a quinazoline moiety, which is made up of two fused six-member aromatic rings, a benzene ring and a pyrimidine ring. Theasaponin e3 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Theasaponin e3 can be found in tea, which makes theasaponin e3 a potential biomarker for the consumption of this food product.

Marcanine D

Bostrycoidin

Riccionidin A

Chromeno [ 3,2-b ] [ 1 ] benzoxol-5-ium-2,3,6,8-tetrol

C15H9O6 (285.0399114)

O1-(3-amino-phenyl)-beta-D-glucopyranuronic acid|O1-(3-Amino-phenyl)-beta-D-glucopyranuronsaeure

C10H14Cl3NO2 (285.00900740000003)

3,3-dimethyl-4-oxo-5-[(S)-3,3,3-trichloro-2-methylpropyl]-2-pyrrolidinone

4-Aminophenyl-beta-D-glucuronide

C12H15NO7

Bezerramycin A

(E)-2-[(3-Indole)cyanomethylene]-3-indolinone

C18H11N3O (285.0902076)

Actinomycinol

Scorazanone

4,9-anhydro-11-deoxyTTX

7,8-Dehydrorutaecarpine

C18H11N3O (285.0902076)

2-Aminophenyl b-D-glucuronide HCl

Nicotinic acid-hexoside

Cladribine

L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C471 - Enzyme Inhibitor > C2157 - Adenosine Deaminase Inhibitor C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D000970 - Antineoplastic Agents CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2617; ORIGINAL_PRECURSOR_SCAN_NO 2616 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2634; ORIGINAL_PRECURSOR_SCAN_NO 2632 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2626; ORIGINAL_PRECURSOR_SCAN_NO 2625 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2623; ORIGINAL_PRECURSOR_SCAN_NO 2621 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2643; ORIGINAL_PRECURSOR_SCAN_NO 2642 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2641; ORIGINAL_PRECURSOR_SCAN_NO 2639 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5653; ORIGINAL_PRECURSOR_SCAN_NO 5650 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5671; ORIGINAL_PRECURSOR_SCAN_NO 5668 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5700; ORIGINAL_PRECURSOR_SCAN_NO 5699 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5680; ORIGINAL_PRECURSOR_SCAN_NO 5677 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5706; ORIGINAL_PRECURSOR_SCAN_NO 5702 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5693; ORIGINAL_PRECURSOR_SCAN_NO 5691 Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].

N4-Acetylcytidine

CONFIDENCE standard compound; INTERNAL_ID 309

7-Aminoclonazepam

C10H12Cl1N5O3 (285.06286320000004)

8-Chloro-deoxyadenosine

2-Chloro-deoxyadenosine

C10H12Cl1N5O3 (285.06286320000004)

4-Acetylcytidine

4-Acetyl-1-(beta-delta-ribofuranosyl)cytosine

N4-Acetylcytidine is an endogenous metabolite. N4-Acetylcytidine is an endogenous metabolite.

2-Methyl-2-propanyl N-(3-bromophenyl)glycinate

2-(BENZOYLAMINO)-4-(METHYLSULFONYL)BUTANOIC ACID

1-(3-bromophenyl)-3,4-dihydroisoquinoline

C15H12BrN (285.0153052)

4-HYDROXY-1-[(4-METHYLPHENYL)SULFONYL]-2-PYRROLIDINECARBOXYLIC ACID

3-AMINO-7-CHLORO-5-PHENYL-1,3-DIHYDRO-BENZO[E][1,4]DIAZEPIN-2-ONE

1-(Pyridin-3-ylmethyl)piperazine trihydrochloride

C10H18Cl3N3 (285.0566238)

5-BROMO-2-BUTYRAMIDOBENZOIC ACID

coumarin 481

2H-1-Benzopyran-2-one, 7-(diethylamino)-4-(trifluoromethyl)-

(2-Methyl-5-(morpholinosulfonyl)phenyl)boronic acid

flunoxaprofen

C16H12FNO3 (285.0801174)

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CC - Antiinflammatory products for vaginal administration C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

2-Fluoroadenosine

2-Fluoroadenosine (2FA) is a nucleoside analogue. 2-Fluoroadenosine has antibacterial activity with IC50 value of 0.842 mM for Vibrio microvibrio[1].

1-(5-BROMOPYRIMIDINE-2-YL)PIPERDINE-3-CARBOXYLIC ACID

1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxylic acid

Piperazine, 1-[4-(methylsulfonyl)-2-nitrophenyl]- (9CI)

9-(trifluoromethyl)-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline-2-carboxylic acid

C12H10F3N3O2 (285.0725076)

2-Deoxy-2-fluoroguanosine

(2R,4S)-4-hydroxy-1-(4-methylphenyl)sulfonyl-pyrrolidine-2-carboxylate

N-(4-Bromo-2-methylphenyl)-3-methoxy-N-methylpropanamide

Methyl 3-(5-Methyl-2-(trifluoromethyl)-1H-indol-3-yl)propanoate

(3S)-3-Benzyl-7a-(trifluoromethyl)tetrahydropyrrolo[2,1-b]oxa-zol-5(6H)-one

(3R)-3-Benzyl-7a-(trifluoromethyl)tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one

N-(3-Methylsulphonyl-4-nitrophenyl)piperazine

4-(Methylsulfonyl)-3-morpholinobenzoic Acid

N-(2,4-DINITROPHENYL)-DL-THREONINE

C10H11N3O7 (285.0596976)

1-(4-Bromophenyl)-2-(4-morpholinyl)ethanol

2-(5-FLUORO-1,3-DIOXO-1,3-DIHYDROISOINDOL-2-YL)BENZOICACID

C15H8FNO4 (285.043734)

silatrane

C12H16ClNO3Si (285.0587936)

N-BOC-N-METHYL-5-CHLOROANTHRANILICACID

ANTHRANILICACID,N-BOC-N-METHYL-4-CHLORO

1-(3-PYRROLIDINOPROYL)HOMOPIPERAZINE

1-(ISOCYANO(TOSYL)METHYL)-2-METHYLBENZENE

Benzenepropanoic acid, β-(acetylamino)-4-bromo-

ETHYL 3-BROMO-7-OXO-4,5,6,7-TETRAHYDRO-1H-INDOLE-2-CARBOXYLATE

7-nitro-4-(pyridin-2-ylmethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

5-(furan-2-yl)-3-p-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide

3-Deoxy-3-fluoroguanosine

dbd-ed

C10H15N5O3S (285.089556)

2-AMINO-6-CHLORO-9-(BETA-D-2-DEOXYRIBOFURANOSYL)PURINE

3-Bromo-4-morpholinobenzoic Acid

1-(5-Bromopyrimidin-2-yl)piperidine-4-carboxylic acid

(E)-Methyl-2-(2-bromomethylphenyl)-2-Methoxyiminoacetate

6-(2-Bromo-ethyl)-1,3-dimethyl-1,6-dihydro-pyrrolo[3,4-d]pyrimidine-2,4-dione

4-Nitrophenylrhamnoside

4-Nitrophenyl α-L-rhamnopyranoside

4-bromo-N,N-diethyl-3-methoxybenzamide

1-(3-Bromo-4-fluorobenzoyl)piperidine

C12H13BrFNO (285.016448)

4-bromo-N-butyl-3-methoxybenzamide

4-BROMO-N-(TERT-BUTYL)-3-METHOXYBENZAMIDE

7,10-Dihydro-8-nitro-7-oxo-1,10-phenanthroline-3-carboxylic acid

C13H7N3O5 (285.0385692)

Ethyl 4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate

Methyl 8-methyl-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-2-carboxylate

6-NITRO-4-(PYRIDINE-2-YLMETHYL)-1,4-BENZOXAZIN-3(4H)-ONE

3-CARBOXYETHYL-2-METHYLBENZOXAZOLIUM BROMIDE

1-pyridin-3-ylmethyl-pyrrolidin-3-ylamine trihydrochloride

C10H18Cl3N3 (285.0566238)

Benzeneacetic acid,2-chloro-a-[[(1,1-dimethylethoxy)carbonyl]amino]-

4-BROMO-N-(TERT-BUTYL)-2-METHOXYBENZAMIDE

4-[2-(4-Bromophenoxy)ethyl]morpholine

N-(3-BROMOPROPYL) 3-BORONOBENZAMIDE

C10H13BBrNO3 (285.0171798)

[5-chloro-2-(cyclopropylmethylamino)phenyl]-phenylmethanone

3-Bromo-5-nitro-2-(piperidin-1-yl)pyridine

5-(2-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

C14H8FN3O3 (285.054967)

Isoxazole,3-(4-chlorophenyl)-5-(4-methoxyphenyl)-

5-Bromo-3-nitro-2-(piperidin-1-yl)pyridine

1-[(4-chlorophenyl)methyl]-5-methylindole-2,3-dione

4-nitrophenyl-beta-l-fucopyranoside

p-Nitrophenyl 6-deoxy-beta-L-galactopyranoside

C12H16ClN3O3 (285.08801359999995)

4-AMINO-N-(2,3-DIMETHYLPHENYL)BENZAMIDE

tert-Butyl (2-bromobenzyl)carbamate

4-[2-(3-Bromophenoxy)ethyl]morpholine

C13H20BrNO (285.07281700000004)

[4-(3-bromopropylcarbamoyl)phenyl]boronic acid

C10H13BBrNO3 (285.0171798)

Methyl 7-fluoro-6-(phenylamino)-1H-benzo[d]imidazole-5-carboxylate

C15H12FN3O2 (285.0913504)

POTASSIUM [2-(BENZYLOXYCARBONYLAMINO)ETHYL] TRIFLUOROBORATE

C10H12BF3KNO2 (285.0550218)

(S)-6-(PROPYLAMINO)-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL HYDROBROMIDE

(s)-n-boc-(2-chlorophenyl)glycine

Adenosine, 8-fluoro-

(3-Bromo-4-Methyl-phenyl)-carbamic acid tert-butyl ester

4-[2-(2-Bromophenoxy)ethyl]morpholine

C13H20BrNO (285.07281700000004)

morphothion

C8H16NO4PS2 (285.0258346)

3-(4-Bromophenoxy)-N,N-diethyl-1-propanamine

Ethyl 4-hydroxy-8-(trifluoromethyl)quinoline-3-carboxylate

Asenapine

(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants An organic heterotetracyclic compound that is 2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole bearing methyl and chloro substituents at positions 2 and 5 respectively. C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Asenapine (Org 5222), an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine can be used in the research of schizophrenia and bipolar disorder[1][2].

Ethyl 5-fluoro-7-(methylsulphonyl)-1H-indole-2-carboxylate

C12H12FNO4S (285.0471044)

dnp-l-threonine

C10H11N3O7 (285.0596976)

2-(4-Chlorophenoxy)-1,3-difluoro-5-nitrobenzene

C12H6ClF2NO3 (285.000426)

1-propenyl-2,3-diMethyliMidazoliuM hexafluorophosphate

C8H16F6N2P (285.0955238)

N-[1-(4-bromophenyl)ethyl]-3-methoxypropanamide

C10H11N3O5S (285.04193960000003)

Nifuratel

G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C514 - Antifungal Agent

3-(2,6-Dichlorophenyl)-N-hydroxy-5-methylisoxazole-4-carboximidamide

C11H9Cl2N3O2 (285.0071794)

4-bromo-2-ethoxy-N-propylbenzamide

5-bromo-N-butyl-2-hydroxy-3-methylbenzamide

N-Benzanilide-4,4-dicarboxylic acid

C10H14F3NO3S (285.06464500000004)

DIETHYL(3-AMINOPROPYL)PHOSPHONATE OXALATE SALT

C9H20NO7P (285.097734)

1H-Indole,5-bromo-1-(phenylmethyl)-

C15H12BrN (285.0153052)

1-Butylpyridinium trifluoromethanesulfonate

tert-Butyl 4-bromobenzylcarbamate

2-Methyl-2-propanyl (3-bromobenzyl)carbamate

(4-(N-(3-Methylbutanoyl)sulfamoyl)phenyl)boronic acid

dimethyl 2-[(2-chloroacetyl)amino]benzene-1,4-dicarboxylate

C12H12ClNO5 (285.0403972)

3-Quinolinecarboxylicacid, 4-hydroxy-7-(trifluoromethyl)-, ethyl ester

C13H17Cl2N3 (285.07994620000005)

2-[4-(5-Bromo-2-pyridinyl)-1-piperazinyl]ethanol

C11H16BrN3O (285.0476666)

2-(1-PIPERAZINYL)-QUINOLINEHYDROCHLORIDE

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-(4-CHLOROPHENYL)ACETIC ACID

(2R)-2-(3-chlorophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid

4-BROMO-2-ETHOXY-N-ISOPROPYLBENZAMIDE

(4-BROMO-2-FLUOROPHENYL)(PIPERIDIN-1-YL)METHANONE

C12H13BrFNO (285.016448)

tert-Butyl (3-(bromomethyl)phenyl)carbamate

7,8-dimethyl-4,5-dioxo-6H-pyrano[3,2-c]quinoline-2-carboxylic acid

2-CARBOXY-PHTHALANIC ACID

TERT-BUTYL 2-(BROMOMETHYL)PHENYLCARBAMATE

tert-Butyl (4-(bromomethyl)phenyl)carbamate

Quinolinium, 1-ethyl-,iodide (1:1)

C11H12IN (285.00144620000003)

2-nitrophenyl β-D-fucoside

Orthonitrophenyl-beta-D-fucopyranoside

1-(ISOCYANO(TOSYL)METHYL)-3-METHYLBENZENE

4-BROMO-6-(2-METHOXYETHOXY)ISOINDOLIN-1-ONE

Ethyl 4-hydroxy-2-(trifluoromethyl)quinoline-3-carboxylate

C8H10F3N3O5 (285.05725259999997)

Ethyl 5-(aminomethyl)-1,3,4-oxadiazole-2-carboxylate

4-nitrophenyl-beta-d-fucopyranoside

(S)-N-ACETYL-4-BROMOPHENYLALANINE

1-BENZYL-4-(DICHLOROMETHYL)-5-NITRO-1H-IMIDAZOLE

C11H9Cl2N3O2 (285.0071794)

7-benzoyl-2,4-dimethyl-2,4,7,8,9-pentazabicyclo[4.3.0]nona-8,10-diene-3,5-dione

C13H11N5O3 (285.0861856)

1-(4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YL)ETHANONE

C13H10F3NOS (285.0435166)

ethyl 2-(4-acetamidophenyl)sulfonylacetate

sodium N-benzylsulphanilate

C13H12NNaO3S (285.0435562)

3-{[(tert-Butoxycarbonyl)amino]methyl}-4-chlorobenzoic acid

N-(4-Methylsulphonyl-3-nitrophenyl)piperazine

4-Bromo-2-morpholinobenzoic Acid

4-(Methylsulfonyl)-2-morpholinobenzoic Acid

2-[2-chloro-3-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]acetic acid

CARBAMIC ACID, N-(2-BROMO-4-METHYLPHENYL)-, 1,1-DIMETHYLETHYL ESTER

8-(4-fluorophenyl)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine

C13H11F4N3 (285.0889054)

N-Boc-(4-Chlorophenyl)glycine

N-Boc-(3-chlorophenyl)glycine

5-Bromo-N-cyclopentyl-3-nitropyridin-2-amine

4-METHYL-3-(MORPHOLINE-4-SULFONYL)BENZOICACID

3-(2,6-DICHLOROPHENYL)-5-METHYLISOXAZOLE-4-CARBOHYDRAZIDE

C11H9Cl2N3O2 (285.0071794)

4-(4-(HYDROXYMETHYL)-2-METHOXY-5-NITROPHENOXY)BUTANOIC ACID

1-METHYL-4-(4-NITRO-BENZENESULFONYL)-PIPERAZINE

5-(1-methylcyclopropyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

C12H10F3N3O2 (285.0725076)

METHYL 2-(MORPHOLINOSULFONYL)BENZOATE

Acid Mordant Orange 14

C14H7NO6 (285.02733620000004)

2-BOC-AMINO-4-BROMOTOLUENE

METHYL 3-METHYL-5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE-4-CARBOXYLATE

3-bromo-4-(2-methylpropanoylamino)benzoic acid

3-bromo-4-(butanoylamino)benzoic acid

Pentyl 4-amino-3-bromobenzoate

1-methylsulfonyl-4-(4-nitrophenyl)piperazine

(2-CHLORO-4-MORPHOLINOTHIENO[3,2-D]PYRIMIDIN-6-YL)METHANOL

C11H12ClN3O2S (285.0338722)

tert-Butyl N-(4-bromo-2-methylphenyl)carbamate

TERT-BUTYL 3-IODOPROPYLCARBAMATE

C8H16INO2 (285.0225746)

METHYL 4-(METHYLSULFONYL)-3-(1H-PYRROL-1-YL)THIOPHENE-2-CARBOXYLATE

C11H11NO4S2 (285.0129486)

L-GAMMA-GLUTAMYL-P-NITROANILIDE MONOHYDRATE

5-BROMO-N-(2-MORPHOLINOETHYL)PYRIDIN-2-AMINE

C11H16BrN3O (285.0476666)

(3-BROMO-5-MORPHOLINOPHENYL)BORONIC ACID

C10H13BBrNO3 (285.0171798)

ETHYL 5-(4-(TRIFLUOROMETHYL)PHENYL)ISOXAZOLE-3-CARBOXYLATE

BENZYL (4-BROMOBUTYL)CARBAMATE

benzyl N-(3-bromo-2-oxopropyl)carbamate

m-chlorophenoxysilatrane

C12H16ClNO3Si (285.0587936)

Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate

3-(perfluorophenyl)benzo[c]isoxazole

C13H4F5NO (285.0213034)

4-[(TETRAHYDRO-FURAN-2-YLMETHYL)-SULFAMOYL]-BENZOIC ACID

N-(4-Cyclopropyl-1-naphthalenyl)-2-formylhydrazinecarbothioamide

2-Iodobiphenyl

C12H4D5I (285.00628429)

Ac-DL-Phe(4-Br)-OH

C11H12Cl2F3N (285.02988480000005)

[3-(methylthio)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]amine hydrochloride

C12H16ClN3OS (285.0702556)

6-Azido-6-deoxy-D-galactopyranose 1-(dihydrogen phosphate)

C6H12N3O8P (285.0362002)

(R)-2-(2-Chloro-5-(trifluoromethyl)phenyl)pyrrolidine hydrochloride

3-(5-BROMO-2-METHOXY-PYRIDIN-3-YL)-ACRYLIC ACID ETHYL ESTER

C5H10F6N5P (285.05779820000004)

2-Azido-1,3-dimethylimidazolinium hexafluorophosphate

1-BENZYL-4-BROMO-1H-INDOLE

C15H12BrN (285.0153052)

3-BROMO-N-(TERT-BUTYL)-4-METHOXYBENZAMIDE

5-(3-TRIFLUOROMETHYLPHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYL ESTER

2-{[(4-Methoxy-3-Methyl-2-Pyridinyl)Methyl]Sulfanyl}-1H-Benzimidazole

1-(PHENYLSULFONYL)-1H-INDOLE-2-CARBALDEHYDE

C15H11NO3S (285.0459616)

(4-Methoxy-3-(pyrrolidin-1-ylsulfonyl)phenyl)boronic acid

1-(5-Bromo-2-fluorobenzyl)-4-methylpiperidine

C13H17BrFN (285.0528314)

1-BOC-5,6-DICHLORO-1H-INDOLE

C13H13Cl2NO2 (285.0323298)

(2-Methyl-4-(morpholinosulfonyl)phenyl)boronic acid

N-Boc-2-(4-chlorophenyl)-DL-glycine

2,5-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl)-, hydrochloride (9CI)

1-(2-nitrophenyl)sulfonylpiperidin-4-amine

1-[2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-6-YL]ETHAN-1-ONE

2′-Deoxy-2′-fluoroguanosine

2′-Deoxy-2′-fluoroguanosine, a nucleoside analog, is a potent inhibitor of influenza virus strains, with an EC90 of <0.35 μM for influenza virus A and B strains. 2′-Deoxy-2′-fluoroguanosine significantly inhibits replication of influenza virus in the upper respiratory tract, resulting in amelioration of fever and nasal inflammation[1][2].

2-AMINOPHENYL-β-D-GLUCURONIC ACID

Adenosine,8-chloro-2-deoxy- (9CI)

1-Isocyano-2-phenylethyl 4-methylphenyl sulfone

10-Methoxyiminostilbene-5-carbonylchloride

1-(Phenylsulfonyl)-3-indolecarboxaldehyde

C15H11NO3S (285.0459616)

2-Bromo-N-cyclopentyl-5-fluorobenzamide

C12H13BrFNO (285.016448)

N-(5-METHYLSULPHONYL-2-NITROPHENYL)PIPERAZINE

methyl 5-bromo-2-(2-methylpropylamino)benzoate

4-(2-Acetamidoethyl)-3-bromobenzoic acid

Methyl 3-bromo-4-(diethylamino)benzoate

3-bromo-4-(diethylaminomethyl)benzoic acid

N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide

C11H12ClN3O2S (285.0338722)

CKI-7 free base is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 free base is a selective Cdc7 kinase inhibitor. CKI-7 free base also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 free base has a much weaker effect on casein kinase II and other protein kinases[1][2][3][4].

N-(beta-D-glucosyl)nicotinate

9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine

C13H8ClN5O (285.0417348)

CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. [1][2].

2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

D000970 - Antineoplastic Agents

5-BENZOXAZOLEACETIC ACID, 2-(4-FLUOROPHENYL)-alpha-METHYL-

C16H12FNO3 (285.0801174)

5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

N-(2-furanylmethyl)-3-methyl-7,8-dihydro-6H-cyclopenta[4,5]thieno[1,2-c]pyrimidin-1-amine

5-methyl-N-[4-(2-pyridinyl)-2-thiazolyl]-2-furancarboxamide

C14H11N3O2S (285.0571946)

3-[2-(3-Methylphenoxy)ethyl]-1,3-benzothiazol-2-one

3-[2-(4-Methylphenoxy)ethyl]-1,3-benzothiazol-2-one

C10H11N3O5S (285.04193960000003)

3-Nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide

1,8-DI-Hydroxy-4-nitro-anthraquinone

C14H7NO6 (285.02733620000004)

(2-Bromoethyl)(2-formyl-4-aminophenyl) acetate

N-[1-[(2R,3S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide

C7H10O10P-3 (285.00115900000003)

7-Phospho-2-dehydro-3-deoxy-D-arabino-heptonate

Kaempferol oxoanion

The 3-oxoanion of kaempferol.

Cyanidin(1-)

An organic anion obtained by selective deprotonation of the 3- and 5-hydroxy groups of cyanidin(1+).

Ponciretin

5,7,2,4-Tetrahydroxyisoflavone

(1S,2R)-1-(1H-indol-3-yl)-3-(phosphonatooxy)propane-1,2-diol

C11H12NO6P-2 (285.0402222)

5-Phosphoribosylglycineamide

C7H14N2O8P- (285.0487754)

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-)

AminoDAHP

C7H12NO9P-2 (285.0249672)

2-Amino-4,5-dihydroxy-6-oxo-7-(phosphooxy)heptanoate

C7H12NO9P-2 (285.0249672)

Fisetin(1-)

A flavonoid oxoanion that is the conjugate base of fisetin.

gentisate 5-O-beta-D-xylopyranoside

C12H13O8- (285.0610398)

D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

(Z)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-3-oxoprop-1-en-1-olate

5-amino-4-chloro-2-(2-hydroxymuconoyl)pyridazin-3(2H)-one

C10H8ClN3O5 (285.0152468)

4-dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naptho-[2,3-c]-pyran-3-(S)-acetic acid

1,6,7,8-tetrahydroxy-2-methylanthraquinone

3-(2,4-Dihydroxyphenyl)-4,7-dihydroxycoumarin

C7H10O10P-3 (285.00115900000003)

3-deoxy-D-arabino-heptulopyranuronate 7-phosphate

3,5,6,7-Tetrahydroxy-2-(4-hydroxyphenyl)chromenium

(2S,4R,5R,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-oxooxane-2-carboxylic acid

C10H11N3O7 (285.0596976)

2-(6-amino-2-fluoro-7H-purin-8-yl)oxane-3,4,5-triol

1-C-(indol-3-yl)glycerol 3-phosphate(2-)

C11H12NO6P-2 (285.0402222)

N(1)-(5-phospho-D-ribosyl)glycinamide(1-)

C7H14N2O8P- (285.0487754)

Conjugate base of N(1)-(5-phospho-D-ribosyl)glycinamide. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Scutellarein(1-)

A flavonoid oxoanion that is the conjugate base of scutellarein, obtained by selective deprotonation of the 7-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

4-butyl-3-(4-chloro-1,5-dimethyl-3-pyrazolyl)-1H-1,2,4-triazole-5-thione

C11H16ClN5S (285.0814886)

N-(1-propyl-5-benzimidazolyl)-2-thiophenecarboxamide

3-[4-(2-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]-1H-pyridazin-6-one

C13H11N5OS (285.0684276)

N-(3-bicyclo[2.2.1]heptanyl)-4-chlorobenzenesulfonamide

C13H16ClNO2S (285.0590226)

7-Chloro-2-methyl-3-(pyridin-4-ylmethyl)quinazolin-4-one

2-O-methyllicodione(1-)

N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2-thiophenecarboxamide

C13H11N5OS (285.0684276)

1-Butyl-3-[[(4,5-dimethyl-3-thiophenyl)-oxomethyl]amino]thiourea

C12H19N3OS2 (285.0969484)

N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-2-thiophenecarboxamide

C14H11N3O2S (285.0571946)

1-Tert-butyl-3-[[(2-chlorophenyl)-oxomethyl]amino]thiourea

C12H16ClN3OS (285.0702556)

3-(3-Pyridinylmethylthio)-6-thiophen-2-ylpyridazine

C14H11N3S2 (285.0394366)

N-[3-(6-imidazo[2,1-b]thiazolyl)phenyl]butanamide

2-(4-Chloro-2-methylphenoxy)acetic acid [2-(ethylamino)-2-oxoethyl] ester

(3-Chloro-phenyl)-(6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl)-amine

C14H12ClN5 (285.0781182)

rubrofusarin B(1-)

A phenolate anion obtained by deprotonation of the 5-hydroxy group of rubrofusarin B. It is the major microspecies at pH 7.3.

6-chloro-4-hydroxy-3-(phenylmethyl)-1H-quinolin-2-one

(2R,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol

(3R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol

Aureusidin-6-olate

An organic anion that is the conjugate base of aureusidin, arising from selective deprotonation of the hydroxy group at position 6 of the benzofuran moiety; major species at pH 7.3.

6beta-[(S)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

5-[2-(2,6-Difluorophenyl)ethyl]-8-quinolinol

C17H13F2NO (285.0965152)

4-[[4-[Nitroso(oxo)methyl]phenyl]hydrazo]benzoic acid

N-(D-glucopyranosyl)nicotinate

[Mo(CO)3Dien]

C7H13MoN3O3+3 (285.0010918)

2,3-dihydrobiochanin A(1-)

Conjugate base of 2,3-dihydrobiochanin A arising from selective deprotonation of the 7-hydroxy group.

(5R)-6-(1-hydroxyethyl)-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

2-hydroxyphenyl beta-D-glucopyranosiduronate

C12H13O8- (285.0610398)

(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(oxolan-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

3-Methyl-4-thiophen-2-yl-2,4,4a,6,7,8-hexahydropyrazolo[3,4-b]quinolin-5-one

C7H10O10P-3 (285.00115900000003)

(2xi)-3-deoxy-7-O-phosphonato-beta-D-threo-hept-6-ulopyranosonate

3,4,8-Trihydroxyflavone-7-olate

C14H8FN3OS (285.03720899999996)

(2E)-2-(5-fluoro-2-oxo-1H-indol-3-ylidene)-2-(4-methyl-1,3-thiazol-2-yl)acetonitrile

(5R,6S)-6-[(1S)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(1R,10S,11R,12R,13S,14R)-3-amino-11-(hydroxymethyl)-6,9-dioxa-2,4-diazapentacyclo[8.3.1.01,7.05,13.08,12]tetradec-3-ene-8,11,14-triol

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] butanoate

C9H20NO7P (285.097734)

5-Chloro-5-deoxyadenosine

6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

(S,S)-asenapine

A 5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole in which both of the stereocentres have S configuration.

(1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate(2-)

C11H12NO6P (285.0402222)

Dianion of (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate arising from deprotonation of both phosphate OH groups.

Faropenem

2-hydroxygenistein(1-)

C15H9O6 (285.0399114)

A flavonoid oxoanion obtained by deprotonation of the 7-hydroxy group of 2-hydroxygenistein. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

(R,R)-asenapine

A 5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole in which both of the stereocentres have R configuration.

1-C-(indol-3-yl)glycerol 3-phosphate(2-)

C11H12NO6P (285.0402222)

An organophosphate oxoanion resulting the from removal of two protons from the phosphate group of 1-C-(indol-3-yl)glycerol 3-phosphate.

luteolin-7-olate

C15H9O6 (285.0399114)

A flavonoid oxoanion that is the conjugate base of luteolin, arising from selective deprotonation of the 7-hydroxy group.

4-nitrophenyl alpha-L-fucoside

C7H10O10P (285.00115900000003)

An alpha-L-fucoside that is alpha-L-fucopyranose in which the anomeric hydroxy hydrogen is replaced by a 4-nitrophenyl group.

catechol beta-D-glucuronide(1-)

C12H13O8 (285.0610398)

A carbohydrate acid derivative anion resulting from the removal of a proton from the carboxy group of catechol beta-D-glucuronide.

7-Phospho-2-dehydro-3-deoxy-D-arabino-heptonate

An organophosphate oxoanion arising from deprotonation of the carboxy and phosphate OH groups of 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonic acid; major species at pH 7.3.

AminoChlorohydroxymuconoyl3(2Hpyridazinone

C10H8ClN3O5 (285.0152468)

LPE 4:0

C9H20NO7P (285.097734)

4'-C-Azidouridine

C9H11N5O6 (285.0709306)

4'-C-azidouridine (4'-Azidouridine) is a uridine analogue. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. 4'-C-Azidouridine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

Nucleoside-Analog-2

C9H11N5O6 (285.0709306)

Nucleoside-Analog-2 is a 4'-Azidocytidine analogue against Hepatitis C virus (HCV) replication. Nucleoside-Analog-2 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

PI3K/Akt/mTOR-IN-2

C17H13F2NO (285.0965152)

PI3K/Akt/mTOR-IN-2 is a PI3K/AKT/mTOR pathway inhibitor. PI3K/Akt/mTOR-IN-2 possess anti-cancer effects and selectivity against MDA-MB-231 cells with IC50 value of 2.29 μM. PI3K/Akt/mTOR-IN-2 can induce cancer cell cycle arrest and apoptosis[1].

SIRT7 inhibitor 97491

SIRT7 inhibitor 97491, a potent SIRT7 inhibitor with an IC50 of 325 nM, reduces deacetylase activity of SIRT7 in a dose-dependent manner. SIRT7 inhibitor 97491 prevents tumor progression by increasing p53 stability through acetylation at K373/382. SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway.[1].

(1r,2s,3s,4s,5r,9s,11s,12s,14r)-7-imino-2-methyl-10,13,15-trioxa-6,8-diazapentacyclo[7.4.1.1³,¹².0⁵,¹¹.0⁵,¹⁴]pentadecane-2,4,12-triol